Clinical Investigation of LY3437943
Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors
Its not destructive, it actually helps with the disease called NAFLD or non-alcoholic fatty liver disease.) Source: Alvin Francisco Official Tiktok Account (@docalvinfrancisco), Tiktok Gluta capsules: Safe ba sa liver? (archived), March 25, 2023, watch from 0:22 to 0:30 He added: Since ang glutathione ay very potent antioxidant, nakakatulong siya sa pagre -reverse ng fatty liver . (Since glutathione is a very potent antioxidant, it helps in reversing fatty liver.) Source: watch from 0:46 to 0:51 To back his statement, the doctor cited a 2017 study that examined the potential therapeutic effects of oral glutathione in 34 Japanese patients diagnosed with NAFLD
Chen J, Guan Z, Wang L, Song G, Ma B, Wang Y
Mounjaro has not been studied in patients with a history of pancreatitis and is not indicated for use in patients with type 1 diabetes mellitus and is not indicated for weight management
